General Information of Drug (ID: DMNFZC6)

Drug Name
Formic Acid Drug Info
Synonyms
formate; Formic acid, ion(1-); HCO2 anion; 71-47-6; formylate; aminate; methanoate; hydrogen carboxylate; CHEMBL183491; formiate; Formate ion; a carboxyl group; Hydrogencarboxylic acid; HCOO-; AC1L18W4; GTPL4540; CTK5I5292; CHEBI:15740; DTXSID60221219; BDAGIHXWWSANSR-UHFFFAOYSA-M; BDBM50155538; STL483235
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
284
ChEBI ID
CHEMBL30751
CAS Number
CAS 64-18-6
TTD Drug ID
DMNFZC6

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DOT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Approved Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
NXN-188 DMMBAIH Migraine 8A80 Phase 2 [5]
NXN-462 DMWVBS2 Headache 8A80-8A84 Phase 2 [6]
L-NIL DM6Y49D N. A. N. A. Terminated [7]
Alpha-D-Mannose DMF5DLW Discovery agent N.A. Investigative [2]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [2]
Flavin-Adenine Dinucleotide DM5S4GK Discovery agent N.A. Investigative [2]
Heme DMGC287 Discovery agent N.A. Investigative [8]
2'-Monophosphoadenosine 5'-Diphosphoribose DME9S8M Discovery agent N.A. Investigative [2]
6-isobutyl-4-methylpyridin-2-amine DM2XB68 Discovery agent N.A. Investigative [9]
7-Methyl-[1,4]thiazepan-(5E)-ylideneamine DMUCJA6 Discovery agent N.A. Investigative [10]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CVBT-141H DMYPXQ2 Coronary artery disease BA80 Phase 2 [11]
Riferminogene pecaplasmid DMBKN4P Critical limb ischemia BD4Y Discontinued in Phase 3 [12]
N,O6-Disulfo-Glucosamine DMYCV7U Discovery agent N.A. Investigative [2]
O2-Sulfo-Glucuronic Acid DME78MS Discovery agent N.A. Investigative [2]
Naphthalene Trisulfonate DML6FI3 Discovery agent N.A. Investigative [2]
5-AMINO-NAPHTALENE-2-MONOSULFONATE DMYTUNE Discovery agent N.A. Investigative [8]
Sucrose Octasulfate DMET64R Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Praziquantel DMOU1PK Flatworm infection 1F70-1F86 Approved [13]
HF-0220 DMI4C90 Alzheimer disease 8A20 Phase 2 [14]
Protoporphyrin IX DMWYE7A Discovery agent N.A. Investigative [15]
Cibacron blue DMWE1N8 Discovery agent N.A. Investigative [16]
S-hexylglutathione DMNWP02 Discovery agent N.A. Investigative [17]
HQL-79 DMSHYQ3 Discovery agent N.A. Investigative [18]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [19]
Sulfamylon DMIO1K0 Bacterial infection 1A00-1C4Z Approved [20]
Dorzolamide DMA17D0 Ocular hypertension 9C61.01 Approved [21]
Chlorothiazide DMLHESP Chronic heart failure BD1Z Approved [22]
Ethoxzolamide DMVO4ED Glaucoma/ocular hypertension 9C61 Approved [8]
Dichlorphenamide DMH7IDQ Chronic glaucoma 9C61.0Z Approved [8]
Cyclothiazide DMJ4AWC Congestive heart failure BD10 Approved [23]
Ethinamate DMK57GB Insomnia 7A00-7A0Z Approved [24]
Benzthiazide DMQWZ0H High blood pressure BA00 Approved [25]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [26]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aminolevulinic acid hci DMS4BLQ Acne vulgaris ED80 Approved [27]
Porphobilinogen DM5HMTB N. A. N. A. Phase 2 [2]
2-Sulfhydryl-Ethanol DMJBO3D Discovery agent N.A. Investigative [2]
S,S-(2-Hydroxyethyl)Thiocysteine DMLPAD8 Discovery agent N.A. Investigative [2]
Delta-Amino Valeric Acid DMV7IAK Discovery agent N.A. Investigative [2]
4,7-Dioxosebacic Acid DML5302 Discovery agent N.A. Investigative [2]
Laevulinic Acid DMTZ17V Discovery agent N.A. Investigative [2]
3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid DMQXPM3 Discovery agent N.A. Investigative [2]
5-Fluorolevulinic Acid DMDV48S Discovery agent N.A. Investigative [2]
4-Oxosebacic Acid DMADSUY Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Heme oxygenase 1 (HMOX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Stannsoporfin DMEG4TC Neonatal hyperbilirubinemia KA87 Phase 2 [28]
Heme DMGC287 Discovery agent N.A. Investigative [8]
2-Propanol, Isopropanol DML5O0H Discovery agent N.A. Investigative [2]
2-Phenylheme DMPIQTE Discovery agent N.A. Investigative [2]
Biliverdine Ix Alpha DMCA0WJ N. A. N. A. Investigative [2]
Verdoheme DM7NRK5 Discovery agent N.A. Investigative [29]
Tin protoporphyrin DMTXJ5S Discovery agent N.A. Investigative [30]
1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone DMOTJWZ Discovery agent N.A. Investigative [8]
12-Phenylheme DMLR2FB Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulfacetamide DMZ6VEY Acne vulgaris ED80 Approved [31]
Sulfoxone DMAYX6P Dermatitis herpetiformis EB44 Approved [31]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [2]
GNF-PF-5134 DM7850H Discovery agent N.A. Investigative [32]
GNF-PF-2272 DMONK0F Discovery agent N.A. Investigative [32]
NSC-66209 DMQ0S4B Discovery agent N.A. Investigative [32]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9200020, Table 3, Compound 1B DMEARS2 N. A. N. A. Patented [33]
US9200020, Table 3, Compound 2B DMXFB5Z N. A. N. A. Patented [33]
US9200020, Table 3 compound 8 DMCLHX5 N. A. N. A. Patented [33]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [2]
Pyrophosphate 2- DMZQ75M Discovery agent N.A. Investigative [8]
Guanosine-5'-Monophosphate DM3SLZK Discovery agent N.A. Investigative [2]
Inosinic Acid DMLR86H Discovery agent N.A. Investigative [2]
Alpha-Phosphoribosylpyrophosphoric Acid DMT6KI7 Discovery agent N.A. Investigative [8]
Carboxylic PRPP DMCTUR1 Discovery agent N.A. Investigative [2]
5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine DMX0EAK Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Glyphosate DM0AFY7 Malaria 1F40-1F45 Investigative [34]
Shikimate-3-Phosphate DMBE0CT Discovery agent N.A. Investigative [2]
Drug Name Drug ID Indication ICD 11 Highest Status REF
GSK1322322 DM1EPMF Bacterial infection 1A00-1C4Z Phase 2 [35]
Actinonin DMT4P89 N. A. N. A. Terminated [36]
Double Oxidized Cysteine DM6TU84 Discovery agent N.A. Investigative [2]
Cysteinesulfonic Acid DMXI8FP Discovery agent N.A. Investigative [2]
3-Sulfinoalanine DMILTRN N. A. N. A. Investigative [2]
HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE DMA4SIN Discovery agent N.A. Investigative [8]
2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE DMWMFTJ Discovery agent N.A. Investigative [8]
[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL DM7NXMB Discovery agent N.A. Investigative [8]
VRC3375 DM1QKVL Discovery agent N.A. Investigative [37]
N-alkyl urea hydroxamic acids DM9T0OK Discovery agent N.A. Investigative [38]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Pendrin (SLC26A4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [39]
Epanova DMHEAGL Hypertriglyceridemia 5C80.1 Approved [40]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [41]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [42]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [43]
CHLORIDE DM1TJXA Solid tumour/cancer 2A00-2F9Z Phase 3 [44]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [45]
IODIDE DM3FZ6P Discovery agent N.A. Investigative [46]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Protein DEK (DEK)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [47]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [48]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [49]
Testosterone DM7HUNW Hot flushes GA30 Approved [50]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [50]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [51]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [52]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [53]
Folic Acid DMEMBJC Colorectal carcinoma Approved [54]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [55]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Phosphoshikimate1-carboxyvinyltransferase (Bact aroA) TTB30PF AROA_ECOLI Inhibitor [2]
Candida Mannose-6-phosphate isomerase (Candi PMI1) TT915ZD MPI_CANAL Inhibitor [2]
Carbonic anhydrase II (CA-II) TTANPDJ CAH2_HUMAN Inhibitor [2]
Delta-aminolevulinic acid dehydratase (ALAD) TTJHKYD HEM2_HUMAN Inhibitor [2]
Glutathione-dependent PGD synthase (HPGDS) TTCYE56 HPGDS_HUMAN Inhibitor [2]
Heme oxygenase 1 (HMOX1) TTI6V2A HMOX1_HUMAN Inhibitor [2]
Heparin-binding growth factor 1 (FGF1) TTMY81X FGF1_HUMAN Inhibitor [2]
Nitric-oxide synthase brain (NOS1) TTZUFI5 NOS1_HUMAN Inhibitor [2]
Plasmodium Hypoxanthine-guanine phosphoribosyltransferase (Malaria LACZ) TTBL49X HGXR_PLAFG Inhibitor [2]
Staphylococcus Peptide deformylase (Stap-coc def) TTICO5G DEF_STAAU Inhibitor [2]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
Pendrin (SLC26A4) OTXUTLVS S26A4_HUMAN Regulation of Drug Effects [3]
Protein DEK (DEK) OTYCJ5H6 DEK_HUMAN Biotransformations [4]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4540).
2 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
3 Human pendrin expressed in Xenopus laevis oocytes mediates chloride/formate exchange. Am J Physiol Cell Physiol. 2000 Jan;278(1):C207-11. doi: 10.1152/ajpcell.2000.278.1.C207.
4 Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis. PLoS One. 2017 May 30;12(5):e0177952. doi: 10.1371/journal.pone.0177952. eCollection 2017.
5 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
6 ClinicalTrials.gov (NCT01748877) Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia. U.S. National Institutes of Health.
7 Discovery of a series of aminopiperidines as novel iNOS inhibitors. Bioorg Med Chem Lett. 2008 Jan 1;18(1):336-43.
8 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
9 Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fl... J Med Chem. 2009 Apr 23;52(8):2443-53.
10 Synthesis of analogs of (1,4)-3- and 5-imino oxazepane, thiazepane, and diazepane as inhibitors of nitric oxide synthases. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5907-11.
11 Clinical pipeline report, company report or official report of CVBT.
12 Riferminogene pecaplasmide. Am J Cardiovasc Drugs. 2010;10(5):343-6.
13 X-ray structure of glutathione S-transferase from Schistosoma japonicum in a new crystal form reveals flexibility of the substrate-binding site. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Mar 1;61(Pt 3):263-5.
14 US patent application no. 2009,0062,529, Multi-cyclic compounds.
15 Inhibition of glutathione-S-transferase from Plasmodium yoelii by protoporphyrin IX, cibacron blue and menadione: implications and therapeutic bene... Parasitol Res. 2008 Mar;102(4):805-7.
16 A novel method for screening the glutathione transferase inhibitors. BMC Biochem. 2009 Mar 16;10:6.
17 Purification and catalytic properties of glutathione transferase from the hepatopancreas of crayfish macrobrachium vollenhovenii (herklots). J Biochem Mol Toxicol. 2004;18(6):332-44.
18 Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J Biol Chem. 2006 Jun 2;281(22):15277-86.
19 Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem. 2008 Aug 1;16(15):7424-8.
20 Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases. J Med Chem. 2010 Apr 8;53(7):2913-26.
21 Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides. Bioorg Med Chem. 2009 Jul 15;17(14):5054-8.
22 Localization of diuretic effects along the loop of Henle: an in vivo microperfusion study in rats. Clin Sci (Lond). 2000 Apr;98(4):481-8.
23 Selective effect of thiazides on the human osteoblast-like cell line MG-63. Kidney Int. 1996 Nov;50(5):1476-82.
24 Inhibition of carbonic anhydrases I and II by N-unsubstituted carbamate esters. J Biol Chem. 1992 Dec 15;267(35):25044-50.
25 Nature of the inhibition of carbonic anhydrase by acetazolamide and benzthiazide. J Pharmacol Exp Ther. 1961 Mar;131:271-4.
26 Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5050-3.
27 Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9.
28 Chemoprevention of severe neonatal hyperbilirubinemia. Semin Perinatol. 2004 Oct;28(5):365-8.
29 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.
30 Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation. 2001 Nov 27;104(22):2710-5.
31 Antifungal Activity of Ag(I) and Zn(II) Complexes of Sulfacetamide Derivatives. Met Based Drugs. 2000;7(1):49-54.
32 In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6.
33 6-oxopurine phosphoribosyltransferase inhibitors. US9200020.
34 Novel molecular targets for antimalarial chemotherapy. Int J Antimicrob Agents. 2007 Jul;30(1):4-10.
35 Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery. Curr Med Chem. 2015;22(2):214-36.
36 Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry. 2000 Feb 15;39(6):1256-62.
37 Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach. Antimicrob Agents Chemother. 2004 Jan;48(1):250-61.
38 N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity. Antimicrob Agents Chemother. 2002 Sep;46(9):2752-64.
39 Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes. Front Pharmacol. 2016 Apr 26;7:111.
40 Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res Treat. 2007 Jan;101(1):7-16. doi: 10.1007/s10549-006-9269-x. Epub 2006 Jul 6.
41 Amiodarone reversibly decreases sodium-iodide symporter mRNA expression at therapeutic concentrations and induces antioxidant responses at supraphysiological concentrations in cultured human thyroid follicles. Thyroid. 2007 Dec;17(12):1189-200. doi: 10.1089/thy.2007.0215.
42 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
43 Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol. 2009 Feb 1;234(3):345-60.
44 Functional characterization of pendrin mutations found in the Israeli and Palestinian populations. Cell Physiol Biochem. 2011;28(3):477-84. doi: 10.1159/000335109. Epub 2011 Nov 18.
45 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
46 Identification of allelic variants of pendrin (SLC26A4) with loss and gain of function. Cell Physiol Biochem. 2011;28(3):467-76. doi: 10.1159/000335108. Epub 2011 Nov 18.
47 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
48 Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. Blood. 2007 May 15;109(10):4450-60.
49 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
50 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
51 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
52 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
53 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
54 Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix. J Nutr Biochem. 2007 Aug;18(8):541-52. doi: 10.1016/j.jnutbio.2006.11.002. Epub 2007 Feb 22.
55 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.